Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease thrombocytopenia
Comorbidity C0685938|gastrointestinal cancer
Sentences 1
PubMedID- 25702890 Previous studies have demonstrated that a peptide-based il-11 antagonist is well tolerated with no thrombocytopenia in gastrointestinal cancer.18 moreover, anti-il-6 antibody has been used in clinical trials for lymphoma, rcc and ovarian cancer.24–26 here, our findings showed that the high expression of il-11 was associated with tumor progression and poor outcome in ccrcc patients.

Page: 1